Florida Pharmacy CE Requirement 20-Hour Package
Included Courses
Courses included in this package. Click on a course to learn more.
- Educating Patients: Creating Teaching Moments in Practice 4Course release date: 12/21/2022
About the Course
Effective education is essential to help patients and family gain knowledge. All healthcare professionals (HCPs) can identify teaching opportunities to assess and provide effective education. The purpose of this course is to provide HCPs with current evidence-based information to help them learn and apply skills and practice for effective patient and family teaching in a variety of settings. - Patient Safety and Medication Errors for Pharmacy Professionals 2
Course Release: 4/1/2024
About the course
This educational program is designed to accomplish at least two important goals: first to provide examples of critical potential medication errors, and secondly to offer mechanisms that pharmacy professionals can take to intervene in these mishaps and enhance patient care. In addition to offering these critical examples and potential solutions, two case studies are included to help put some of the ideas into realistic scenarios similar to those that may be encountered in contemporary pharmacy practice. Evidence-based practice information from current peer-reviewed literature is also included for context and ideas for pharmacists to consider in efforts to improve their practice appear throughout the program. Lastly, a post-test is included at the end of the program to test your understanding of the material.
- Prescribing Controlled Substances Safely: A DEA Requirement 8
Course release date: 5/1/2023
About the Course
Nurse Practitioners (NPs), Pharmacists, and Dentists care for patients with disorders in many healthcare settings. Individuals may seek care for an acute illness or worsening of a chronic condition. Often, pain is the leading reason for seeking medical care. Appropriate prescribing practices are critical for all medications, but controlled substances require special attention. The Drug Enforcement Agency (DEA), the Food and Drug Administration (FDA), and the U.S. Department of Health and Human Services (HHS) all have a role in controlled medication schedules. Prescribers must understand federal and state requirements for all controlled substances. This course will provide a general review of federal and state-controlled substance regulations and the prescribing practices for controlled substances. Additionally, substance use disorders are complex phenomena affecting many lives. This course also reviews common substance use disorders, including alcohol, anxiolytics, stimulants, hallucinogens, and tobacco/vaping. However, the focus is on clinical safety considerations when prescribing non-cancer-related opioid medications for acute/chronic pain in adults.
- The Validation of Controlled Drug Prescriptions in Florida, 2nd Edition 2
Course Release: 12/14/2023
About the course
This course is intended for all pharmacists licensed in the state of Florida. The course discusses the interpretation and compliance with Florida laws regarding controlled substances prescriptions. The course also includes information on the Prescription Drug Monitoring Program, the use of naloxone, proper storage and disposal of controlled substances, resolving drug therapy problems, and pharmacist-initiated patient counseling for opioid prescriptions. Learners will be equipped to identify and provide support for patients experiencing or at risk for opioid dependence, addiction, misuse, or abuse.
- Understanding the FDA’s Medication Safety Initiatives 4
Course Release: 1/9/2024
About the course
In 2022 over 6.7 billion prescriptions were dispensed (Matej Mikulic, 2023, September 15). This number increases each year. The U.S. Food and Drug Administration (FDA) and its Center for Drug Evaluation and Research (CDER) agency is responsible for approving, monitoring, educating, and evaluating the safety and effectiveness evaluation of both prescription and over-the counter drugs as well as medical devices. This course presents an overview of the FDA’s history, its current role in safety monitoring, drug effectiveness, and supply of medications in the United States. The agency maintains many different databases and publications related to drug safety and availability which are available to both the healthcare professionals and consumers. As healthcare providers, it is critical to understand many of these resources and to know which ones are applicable to your profession. This course provides an overview of many of the important resources that the FDA provides as well as how to access the information, how to report concerns and how to stay current as the landscape of drug availability continually changes in the United States.